FDA
-
-
-
-
-
-
-
Immuron (IMRN) US DoD Naval Medical Research Center responds to FDA Clinical Hold for New Campylobacter ETEC Therapeutic
-
-
-
-
-
-
-
Immuron (IMRN) Reports Study of New Campylobacter ETEC Therapeutic Halted
-
-
-
-
-
-
-
US DoD Naval Medical Research Center Clinical Update
-
-
-
-
-
-
-
Immuron (IMRN) Announces $20 Million Registered Direct Offering of ADSs
-
-
-
-
-
-
-
US DoD Naval Medical Research Center Requests Meeting with FDA for Guidance on two Phase 2 trials to Prevent Acute Infectious Diarrhea
-
-
-
-
-
-
-
North American Travelan® sales up 98% in the first half of FY20
-
-
-
-
-
-
-
Immuron Reports Results in Severe Alcoholic Hepatitis Clinical Trial
-
312,667 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

